Anti-NeuN Antibody - Global and China Top Players Market Share and Ranking 2023
According to the Latest Research Report,, the global market for Anti-NeuN Antibody should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
Growing patient base, launch of novel anti-neuronal antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in revenue of the anti-neuronal antibody market.
NeuN is a reported synonym of the human protein 'RNA binding fox-1 homolog 3', encoded by the gene RBFOX3. The full protein is reported to be 312 amino acid residues in length. The NeuN antigen is a documented neuronal marker.
This report studies and analyses global Anti-NeuN Antibody status and future trends, helps the client to determine the Anti-NeuN Antibody market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Anti-NeuN Antibody, and provides market size (in L & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Anti-NeuN Antibody market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (L)
(2) Global Anti-NeuN Antibody sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (L)
(3) China Anti-NeuN Antibody sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (L)
(4) Global Anti-NeuN Antibody key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Anti-NeuN Antibody key producing regions, capacity, production, and year over year growth
(6) Anti-NeuN Antibody industry chains, upstream, midstream and downstream
Market segment by players, this report covers
GeneTex
Novus Biologicals
Bioss
United States Biological
Thermo Fisher Scientific
Biorbyt
Synaptic Systems GmbH
LifeSpan BioSciences
NSJ Bioreagents
EpiGentek
Cell Signaling Technology
G Biosciences
Abcam
HUABIO
Enzo Life Sciences
RayBiotech
Merck
Bio-Rad
RevMAb Biosciences
Miltenyi Biotec
Leading Biology
Market segment by Type, covers
Monoclonal
Polyclonal
Market segment by Application, can be divided into
Immunofluorescence (IF)
Immunochemistry (IHC)
Western Blot (WB)
ELISA
Others
Key Regions Covered in This Report Are:
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
The Report Consists of The Following Points:
Chapter 1: to describe Anti-NeuN Antibody product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Anti-NeuN Antibody market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Anti-NeuN Antibody market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Anti-NeuN Antibody, percent & CAGR, 2018-2029
Chapter 5: Anti-NeuN Antibody industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Anti-NeuN Antibody Definition
1.2 Global Anti-NeuN Antibody Market Size and Forecast
1.2.1 By Consumption Value, Global Anti-NeuN Antibody Market Size，2018-2029
1.2.2 By Sales Quantity, Global Anti-NeuN Antibody Market Size，2018-2029
1.2.3 Global Anti-NeuN Antibody Average Selling Price (ASP)，2018-2029
1.3 China Anti-NeuN Antibody Market Size and Forecast
1.3.1 By Consumption Value, China Anti-NeuN Antibody Market Size，2018-2029
1.3.2 By Sales Quantity, China Anti-NeuN Antibody Market Size，2018-2029
1.3.3 China Anti-NeuN Antibody Average Selling Price (ASP)， 2018-2029
1.4 Share of China Anti-NeuN Antibody Market with Respect to the Global Market
1.4.1 By Consumption Value, China Anti-NeuN Antibody Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Anti-NeuN Antibody Market Share in Global, 2018-2029
1.4.3 Anti-NeuN Antibody Market Size: China VS Global, 2018-2029
1.5 Anti-NeuN Antibody Market Dynamics
1.5.1 Anti-NeuN Antibody Market Drivers
1.5.2 Anti-NeuN Antibody Market Restraints
1.5.3 Anti-NeuN Antibody Industry Trends
1.5.4 Anti-NeuN Antibody Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Anti-NeuN Antibody, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Anti-NeuN Antibody, Global Market Share by Company, 2018-2023
2.3 Anti-NeuN Antibody Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Anti-NeuN Antibody Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Anti-NeuN Antibody Concentration Ratio
2.6 Global Anti-NeuN Antibody Mergers & Acquisitions, Expansion Plans
2.7 Global Anti-NeuN Antibody Manufacturers Product Type
2.8 Head Office and Anti-NeuN Antibody Production Site of Key Manufacturer
2.9 Anti-NeuN Antibody Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Anti-NeuN Antibody, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Anti-NeuN Antibody, China Market Share by Company, 2018-2023
3.3 China Anti-NeuN Antibody Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Anti-NeuN Antibody Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Anti-NeuN Antibody Capacity by Region
4.3 Global Anti-NeuN Antibody Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Anti-NeuN Antibody Production by Region, 2018-2029
4.5 Global Anti-NeuN Antibody Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Anti-NeuN Antibody Industry Chain
5.2 Anti-NeuN Antibody Upstream Analysis
5.2.1 Anti-NeuN Antibody Core Raw Materials
5.2.2 Main Manufacturers of Anti-NeuN Antibody Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Anti-NeuN Antibody Production Mode
5.6 Anti-NeuN Antibody Procurement Model
5.7 Anti-NeuN Antibody Industry Sales Model and Sales Channels
5.7.1 Anti-NeuN Antibody Sales Model
5.7.2 Anti-NeuN Antibody Typical Distributors
6 Sights by Type
6.1 Anti-NeuN Antibody Classification
6.1.1 Monoclonal
6.1.2 Polyclonal
6.2 By Type, Global Anti-NeuN Antibody Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Anti-NeuN Antibody Consumption Value, 2018-2029
6.4 By Type, Global Anti-NeuN Antibody Sales Quantity, 2018-2029
6.5 By Type, Global Anti-NeuN Antibody Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Anti-NeuN Antibody Segment by Application
7.1.1 Immunofluorescence (IF)
7.1.2 Immunochemistry (IHC)
7.1.3 Western Blot (WB)
7.1.4 ELISA
7.1.5 Others
7.2 By Application, Global Anti-NeuN Antibody Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Anti-NeuN Antibody Consumption Value, 2018-2029
7.4 By Application, Global Anti-NeuN Antibody Sales Quantity, 2018-2029
7.5 By Application, Global Anti-NeuN Antibody Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Anti-NeuN Antibody Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Anti-NeuN Antibody Consumption Value, 2018-2029
8.3 By Region, Global Anti-NeuN Antibody Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Anti-NeuN Antibody & Forecasts, 2018-2029
8.4.2 By Country, North America Anti-NeuN Antibody Market Size Market Share
8.5 Europe
8.5.1 Europe Anti-NeuN Antibody Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Anti-NeuN Antibody Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Anti-NeuN Antibody Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Anti-NeuN Antibody Market Size Market Share
8.7 South America
8.7.1 South America Anti-NeuN Antibody Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Anti-NeuN Antibody Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Anti-NeuN Antibody Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Anti-NeuN Antibody Consumption Value, 2018-2029
9.3 By Country, Global Anti-NeuN Antibody Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Anti-NeuN Antibody Market Size, 2018-2029
9.4.2 By Type, U.S. Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Anti-NeuN Antibody Market Size, 2018-2029
9.5.2 By Type, Europe Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Anti-NeuN Antibody Market Size, 2018-2029
9.6.2 By Type, China Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Anti-NeuN Antibody Market Size, 2018-2029
9.7.2 By Type, Japan Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Anti-NeuN Antibody Market Size, 2018-2029
9.8.2 By Type, South Korea Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Anti-NeuN Antibody Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Anti-NeuN Antibody Market Size, 2018-2029
9.10.2 By Type, India Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Anti-NeuN Antibody Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 GeneTex
10.1.1 GeneTex Company Information, Head Office, Market Area, and Industry Position
10.1.2 GeneTex Anti-NeuN Antibody Models, Specifications, and Application
10.1.3 GeneTex Anti-NeuN Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 GeneTex Company Profile and Main Business
10.1.5 GeneTex Recent Developments
10.2 Novus Biologicals
10.2.1 Novus Biologicals Company Information, Head Office, Market Area, and Industry Position
10.2.2 Novus Biologicals Anti-NeuN Antibody Models, Specifications, and Application
10.2.3 Novus Biologicals Anti-NeuN Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Novus Biologicals Company Profile and Main Business
10.2.5 Novus Biologicals Recent Developments
10.3 Bioss
10.3.1 Bioss Company Information, Head Office, Market Area, and Industry Position
10.3.2 Bioss Anti-NeuN Antibody Models, Specifications, and Application
10.3.3 Bioss Anti-NeuN Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Bioss Company Profile and Main Business
10.3.5 Bioss Recent Developments
10.4 United States Biological
10.4.1 United States Biological Company Information, Head Office, Market Area, and Industry Position
10.4.2 United States Biological Anti-NeuN Antibody Models, Specifications, and Application
10.4.3 United States Biological Anti-NeuN Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 United States Biological Company Profile and Main Business
10.4.5 United States Biological Recent Developments
10.5 Thermo Fisher Scientific
10.5.1 Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position
10.5.2 Thermo Fisher Scientific Anti-NeuN Antibody Models, Specifications, and Application
10.5.3 Thermo Fisher Scientific Anti-NeuN Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Thermo Fisher Scientific Company Profile and Main Business
10.5.5 Thermo Fisher Scientific Recent Developments
10.6 Biorbyt
10.6.1 Biorbyt Company Information, Head Office, Market Area, and Industry Position
10.6.2 Biorbyt Anti-NeuN Antibody Models, Specifications, and Application
10.6.3 Biorbyt Anti-NeuN Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Biorbyt Company Profile and Main Business
10.6.5 Biorbyt Recent Developments
10.7 Synaptic Systems GmbH
10.7.1 Synaptic Systems GmbH Company Information, Head Office, Market Area, and Industry Position
10.7.2 Synaptic Systems GmbH Anti-NeuN Antibody Models, Specifications, and Application
10.7.3 Synaptic Systems GmbH Anti-NeuN Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Synaptic Systems GmbH Company Profile and Main Business
10.7.5 Synaptic Systems GmbH Recent Developments
10.8 LifeSpan BioSciences
10.8.1 LifeSpan BioSciences Company Information, Head Office, Market Area, and Industry Position
10.8.2 LifeSpan BioSciences Anti-NeuN Antibody Models, Specifications, and Application
10.8.3 LifeSpan BioSciences Anti-NeuN Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 LifeSpan BioSciences Company Profile and Main Business
10.8.5 LifeSpan BioSciences Recent Developments
10.9 NSJ Bioreagents
10.9.1 NSJ Bioreagents Company Information, Head Office, Market Area, and Industry Position
10.9.2 NSJ Bioreagents Anti-NeuN Antibody Models, Specifications, and Application
10.9.3 NSJ Bioreagents Anti-NeuN Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 NSJ Bioreagents Company Profile and Main Business
10.9.5 NSJ Bioreagents Recent Developments
10.10 EpiGentek
10.10.1 EpiGentek Company Information, Head Office, Market Area, and Industry Position
10.10.2 EpiGentek Anti-NeuN Antibody Models, Specifications, and Application
10.10.3 EpiGentek Anti-NeuN Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 EpiGentek Company Profile and Main Business
10.10.5 EpiGentek Recent Developments
10.11 Cell Signaling Technology
10.11.1 Cell Signaling Technology Company Information, Head Office, Market Area, and Industry Position
10.11.2 Cell Signaling Technology Anti-NeuN Antibody Models, Specifications, and Application
10.11.3 Cell Signaling Technology Anti-NeuN Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Cell Signaling Technology Company Profile and Main Business
10.11.5 Cell Signaling Technology Recent Developments
10.12 G Biosciences
10.12.1 G Biosciences Company Information, Head Office, Market Area, and Industry Position
10.12.2 G Biosciences Anti-NeuN Antibody Models, Specifications, and Application
10.12.3 G Biosciences Anti-NeuN Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 G Biosciences Company Profile and Main Business
10.12.5 G Biosciences Recent Developments
10.13 Abcam
10.13.1 Abcam Company Information, Head Office, Market Area, and Industry Position
10.13.2 Abcam Anti-NeuN Antibody Models, Specifications, and Application
10.13.3 Abcam Anti-NeuN Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Abcam Company Profile and Main Business
10.13.5 Abcam Recent Developments
10.14 HUABIO
10.14.1 HUABIO Company Information, Head Office, Market Area, and Industry Position
10.14.2 HUABIO Anti-NeuN Antibody Models, Specifications, and Application
10.14.3 HUABIO Anti-NeuN Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 HUABIO Company Profile and Main Business
10.14.5 HUABIO Recent Developments
10.15 Enzo Life Sciences
10.15.1 Enzo Life Sciences Company Information, Head Office, Market Area, and Industry Position
10.15.2 Enzo Life Sciences Anti-NeuN Antibody Models, Specifications, and Application
10.15.3 Enzo Life Sciences Anti-NeuN Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Enzo Life Sciences Company Profile and Main Business
10.15.5 Enzo Life Sciences Recent Developments
10.16 RayBiotech
10.16.1 RayBiotech Company Information, Head Office, Market Area, and Industry Position
10.16.2 RayBiotech Anti-NeuN Antibody Models, Specifications, and Application
10.16.3 RayBiotech Anti-NeuN Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 RayBiotech Company Profile and Main Business
10.16.5 RayBiotech Recent Developments
10.17 Merck
10.17.1 Merck Company Information, Head Office, Market Area, and Industry Position
10.17.2 Merck Anti-NeuN Antibody Models, Specifications, and Application
10.17.3 Merck Anti-NeuN Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Merck Company Profile and Main Business
10.17.5 Merck Recent Developments
10.18 Bio-Rad
10.18.1 Bio-Rad Company Information, Head Office, Market Area, and Industry Position
10.18.2 Bio-Rad Anti-NeuN Antibody Models, Specifications, and Application
10.18.3 Bio-Rad Anti-NeuN Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.18.4 Bio-Rad Company Profile and Main Business
10.18.5 Bio-Rad Recent Developments
10.19 RevMAb Biosciences
10.19.1 RevMAb Biosciences Company Information, Head Office, Market Area, and Industry Position
10.19.2 RevMAb Biosciences Anti-NeuN Antibody Models, Specifications, and Application
10.19.3 RevMAb Biosciences Anti-NeuN Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.19.4 RevMAb Biosciences Company Profile and Main Business
10.19.5 RevMAb Biosciences Recent Developments
10.20 Miltenyi Biotec
10.20.1 Miltenyi Biotec Company Information, Head Office, Market Area, and Industry Position
10.20.2 Miltenyi Biotec Anti-NeuN Antibody Models, Specifications, and Application
10.20.3 Miltenyi Biotec Anti-NeuN Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.20.4 Miltenyi Biotec Company Profile and Main Business
10.20.5 Miltenyi Biotec Recent Developments
10.21 Leading Biology
10.21.1 Leading Biology Company Information, Head Office, Market Area, and Industry Position
10.21.2 Leading Biology Anti-NeuN Antibody Models, Specifications, and Application
10.21.3 Leading Biology Anti-NeuN Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.21.4 Leading Biology Company Profile and Main Business
10.21.5 Leading Biology Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Anti-NeuN Antibody Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Anti-NeuN Antibody Market Restraints
Table 3. Anti-NeuN Antibody Market Trends
Table 4. Anti-NeuN Antibody Industry Policy
Table 5. Global Anti-NeuN Antibody Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Anti-NeuN Antibody Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Anti-NeuN Antibody Sales Quantity by Company, (2018-2023) & (L), Ranked Based on Sales in 2022
Table 8. Global Anti-NeuN Antibody Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Anti-NeuN Antibody Average Selling Price (ASP) by Company, (2018-2023) & (US$/L)
Table 10. Global Anti-NeuN Antibody Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Anti-NeuN Antibody Mergers & Acquisitions, Expansion Plans
Table 12. Global Anti-NeuN Antibody Manufacturers Product Type
Table 13. Head Office and Anti-NeuN Antibody Production Site of Key Manufacturer
Table 14. Anti-NeuN Antibody Capacity of Major Manufacturers and Future Plan
Table 15. China Anti-NeuN Antibody Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Anti-NeuN Antibody Sales Quantity by Company, (2018-2023) & (L), Ranked Based on Sales in 2022
Table 17. China Anti-NeuN Antibody Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Anti-NeuN Antibody Production & Forecast by Region, 2018 VS 2022 VS 2029, (L)
Table 19. Global Anti-NeuN Antibody Production by Region, 2018-2023, (L)
Table 20. Global Anti-NeuN Antibody Production Forecast by Region, 2024-2029, (L)
Table 21. Global Key Players of Anti-NeuN Antibody Upstream (Raw Materials)
Table 22. Global Anti-NeuN Antibody Typical Customers
Table 23. Anti-NeuN Antibody Typical Distributors
Table 24. By Type, Global Anti-NeuN Antibody Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Anti-NeuN Antibody Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Anti-NeuN Antibody Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Anti-NeuN Antibody Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Anti-NeuN Antibody Sales Quantity, 2018-2029, (L)
Table 29. By Country, Global Anti-NeuN Antibody Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Anti-NeuN Antibody Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Anti-NeuN Antibody Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Anti-NeuN Antibody Sales Quantity, 2018-2029, (L)
Table 33. By Country, Global Anti-NeuN Antibody Sales Quantity Market Share, 2018-2029
Table 34. GeneTex Company Information, Head Office, Market Area, and Industry Position
Table 35. GeneTex Anti-NeuN Antibody Models, Specifications, and Application
Table 36. GeneTex Anti-NeuN Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 37. GeneTex Company Profile and Main Business
Table 38. GeneTex Recent Developments
Table 39. Novus Biologicals Company Information, Head Office, Market Area, and Industry Position
Table 40. Novus Biologicals Anti-NeuN Antibody Models, Specifications, and Application
Table 41. Novus Biologicals Anti-NeuN Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 42. Novus Biologicals Company Profile and Main Business
Table 43. Novus Biologicals Recent Developments
Table 44. Bioss Company Information, Head Office, Market Area, and Industry Position
Table 45. Bioss Anti-NeuN Antibody Models, Specifications, and Application
Table 46. Bioss Anti-NeuN Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 47. Bioss Company Profile and Main Business
Table 48. Bioss Recent Developments
Table 49. United States Biological Company Information, Head Office, Market Area, and Industry Position
Table 50. United States Biological Anti-NeuN Antibody Models, Specifications, and Application
Table 51. United States Biological Anti-NeuN Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 52. United States Biological Company Profile and Main Business
Table 53. United States Biological Recent Developments
Table 54. Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position
Table 55. Thermo Fisher Scientific Anti-NeuN Antibody Models, Specifications, and Application
Table 56. Thermo Fisher Scientific Anti-NeuN Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 57. Thermo Fisher Scientific Company Profile and Main Business
Table 58. Thermo Fisher Scientific Recent Developments
Table 59. Biorbyt Company Information, Head Office, Market Area, and Industry Position
Table 60. Biorbyt Anti-NeuN Antibody Models, Specifications, and Application
Table 61. Biorbyt Anti-NeuN Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 62. Biorbyt Company Profile and Main Business
Table 63. Biorbyt Recent Developments
Table 64. Synaptic Systems GmbH Company Information, Head Office, Market Area, and Industry Position
Table 65. Synaptic Systems GmbH Anti-NeuN Antibody Models, Specifications, and Application
Table 66. Synaptic Systems GmbH Anti-NeuN Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 67. Synaptic Systems GmbH Company Profile and Main Business
Table 68. Synaptic Systems GmbH Recent Developments
Table 69. LifeSpan BioSciences Company Information, Head Office, Market Area, and Industry Position
Table 70. LifeSpan BioSciences Anti-NeuN Antibody Models, Specifications, and Application
Table 71. LifeSpan BioSciences Anti-NeuN Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 72. LifeSpan BioSciences Company Profile and Main Business
Table 73. LifeSpan BioSciences Recent Developments
Table 74. NSJ Bioreagents Company Information, Head Office, Market Area, and Industry Position
Table 75. NSJ Bioreagents Anti-NeuN Antibody Models, Specifications, and Application
Table 76. NSJ Bioreagents Anti-NeuN Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 77. NSJ Bioreagents Company Profile and Main Business
Table 78. NSJ Bioreagents Recent Developments
Table 79. EpiGentek Company Information, Head Office, Market Area, and Industry Position
Table 80. EpiGentek Anti-NeuN Antibody Models, Specifications, and Application
Table 81. EpiGentek Anti-NeuN Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 82. EpiGentek Company Profile and Main Business
Table 83. EpiGentek Recent Developments
Table 84. Cell Signaling Technology Company Information, Head Office, Market Area, and Industry Position
Table 85. Cell Signaling Technology Anti-NeuN Antibody Models, Specifications, and Application
Table 86. Cell Signaling Technology Anti-NeuN Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 87. Cell Signaling Technology Company Profile and Main Business
Table 88. Cell Signaling Technology Recent Developments
Table 89. G Biosciences Company Information, Head Office, Market Area, and Industry Position
Table 90. G Biosciences Anti-NeuN Antibody Models, Specifications, and Application
Table 91. G Biosciences Anti-NeuN Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 92. G Biosciences Company Profile and Main Business
Table 93. G Biosciences Recent Developments
Table 94. Abcam Company Information, Head Office, Market Area, and Industry Position
Table 95. Abcam Anti-NeuN Antibody Models, Specifications, and Application
Table 96. Abcam Anti-NeuN Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 97. Abcam Company Profile and Main Business
Table 98. Abcam Recent Developments
Table 99. HUABIO Company Information, Head Office, Market Area, and Industry Position
Table 100. HUABIO Anti-NeuN Antibody Models, Specifications, and Application
Table 101. HUABIO Anti-NeuN Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 102. HUABIO Company Profile and Main Business
Table 103. HUABIO Recent Developments
Table 104. Enzo Life Sciences Company Information, Head Office, Market Area, and Industry Position
Table 105. Enzo Life Sciences Anti-NeuN Antibody Models, Specifications, and Application
Table 106. Enzo Life Sciences Anti-NeuN Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 107. Enzo Life Sciences Company Profile and Main Business
Table 108. Enzo Life Sciences Recent Developments
Table 109. RayBiotech Company Information, Head Office, Market Area, and Industry Position
Table 110. RayBiotech Anti-NeuN Antibody Models, Specifications, and Application
Table 111. RayBiotech Anti-NeuN Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 112. RayBiotech Company Profile and Main Business
Table 113. RayBiotech Recent Developments
Table 114. Merck Company Information, Head Office, Market Area, and Industry Position
Table 115. Merck Anti-NeuN Antibody Models, Specifications, and Application
Table 116. Merck Anti-NeuN Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 117. Merck Company Profile and Main Business
Table 118. Merck Recent Developments
Table 119. Bio-Rad Company Information, Head Office, Market Area, and Industry Position
Table 120. Bio-Rad Anti-NeuN Antibody Models, Specifications, and Application
Table 121. Bio-Rad Anti-NeuN Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 122. Bio-Rad Company Profile and Main Business
Table 123. Bio-Rad Recent Developments
Table 124. RevMAb Biosciences Company Information, Head Office, Market Area, and Industry Position
Table 125. RevMAb Biosciences Anti-NeuN Antibody Models, Specifications, and Application
Table 126. RevMAb Biosciences Anti-NeuN Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 127. RevMAb Biosciences Company Profile and Main Business
Table 128. RevMAb Biosciences Recent Developments
Table 129. Miltenyi Biotec Company Information, Head Office, Market Area, and Industry Position
Table 130. Miltenyi Biotec Anti-NeuN Antibody Models, Specifications, and Application
Table 131. Miltenyi Biotec Anti-NeuN Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 132. Miltenyi Biotec Company Profile and Main Business
Table 133. Miltenyi Biotec Recent Developments
Table 134. Leading Biology Anti-NeuN Antibody Company Information, Head Office, Market Area, and Industry Position
Table 135. Leading Biology Anti-NeuN Antibody Models, Specifications, and Application
Table 136. Leading Biology Anti-NeuN Antibody Sales Quantity (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 137. Leading Biology Company Profile and Main Business
Table 138. Leading Biology Recent Developments
List of Figures
Figure 1. Anti-NeuN Antibody Picture
Figure 2. Global Anti-NeuN Antibody Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Anti-NeuN Antibody Sales Quantity, (L) & (2018-2029)
Figure 4. Global Anti-NeuN Antibody Average Selling Price (ASP), (2018-2029) & (US$/L)
Figure 5. China Anti-NeuN Antibody Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Anti-NeuN Antibody Sales Quantity (L) & (2018-2029)
Figure 7. China Anti-NeuN Antibody Average Selling Price (ASP), (US$/L) & (2018-2029)
Figure 8. By Consumption Value, China Anti-NeuN Antibody Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Anti-NeuN Antibody Market Share of Global, 2018-2029
Figure 10. Global Anti-NeuN Antibody Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Anti-NeuN Antibody Key Participants, Market Share, 2022
Figure 12. Global Anti-NeuN Antibody Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Anti-NeuN Antibody Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Anti-NeuN Antibody Production Market Share & Forecast by Region, 2018-2029
Figure 15. Anti-NeuN Antibody Industry Chain
Figure 16. Anti-NeuN Antibody Procurement Model
Figure 17. Anti-NeuN Antibody Sales Model
Figure 18. Anti-NeuN Antibody Sales Channels, Direct Sales, and Distribution
Figure 19. Monoclonal
Figure 20. Polyclonal
Figure 21. By Type, Global Anti-NeuN Antibody Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Anti-NeuN Antibody Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Anti-NeuN Antibody Sales Quantity, 2018-2029, (L)
Figure 24. By Type, Global Anti-NeuN Antibody Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Anti-NeuN Antibody Average Selling Price (ASP), 2018-2029, (US$/L)
Figure 26. Immunofluorescence (IF)
Figure 27. Immunochemistry (IHC)
Figure 28. Western Blot (WB)
Figure 29. ELISA
Figure 30. Others
Figure 31. By Application, Global Anti-NeuN Antibody Consumption Value, 2018-2029, US$ Million
Figure 32. By Application, Global Anti-NeuN Antibody Consumption Value Market Share, 2018-2029
Figure 33. By Application, Global Anti-NeuN Antibody Sales Quantity, 2018-2029, (L)
Figure 34. By Application, Global Anti-NeuN Antibody Sales Quantity Market Share, 2018-2029
Figure 35. By Application, Global Anti-NeuN Antibody Average Selling Price (ASP), 2018-2029, (US$/L)
Figure 36. By Region, Global Anti-NeuN Antibody Consumption Value Market Share, 2018-2029
Figure 37. By Region, Global Anti-NeuN Antibody Sales Quantity Market Share, 2018-2029
Figure 38. North America Anti-NeuN Antibody Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, North America Anti-NeuN Antibody Consumption Value Market Share, 2022
Figure 40. Europe Anti-NeuN Antibody Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, Europe Anti-NeuN Antibody Consumption Value Market Share, 2022
Figure 42. Asia Pacific Anti-NeuN Antibody Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country/Region, Asia Pacific Anti-NeuN Antibody Consumption Value Market Share, 2022
Figure 44. South America Anti-NeuN Antibody Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, South America Anti-NeuN Antibody Consumption Value Market Share, 2022
Figure 46. Middle East & Africa Anti-NeuN Antibody Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 47. U.S. Anti-NeuN Antibody Sales Quantity, 2018-2029, (L)
Figure 48. By Type, U.S. Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, U.S. Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 50. Europe Anti-NeuN Antibody Sales Quantity, 2018-2029, (L)
Figure 51. By Type, Europe Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, Europe Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 53. China Anti-NeuN Antibody Sales Quantity, 2018-2029, (L)
Figure 54. By Type, China Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, China Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 56. Japan Anti-NeuN Antibody Sales Quantity, 2018-2029, (L)
Figure 57. By Type, Japan Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, Japan Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 59. South Korea Anti-NeuN Antibody Sales Quantity, 2018-2029, (L)
Figure 60. By Type, South Korea Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, South Korea Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 62. Southeast Asia Anti-NeuN Antibody Sales Quantity, 2018-2029, (L)
Figure 63. By Type, Southeast Asia Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, Southeast Asia Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 65. India Anti-NeuN Antibody Sales Quantity, 2018-2029, (L)
Figure 66. By Type, India Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, India Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 68. Middle East & Africa Anti-NeuN Antibody Sales Quantity, 2018-2029, (L)
Figure 69. By Type, Middle East & Africa Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 70. By Application, Middle East & Africa Anti-NeuN Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 71. Research Methodology
Figure 72. Breakdown of Primary Interviews
Figure 73. Bottom-up and Top-down Approaches
Figure 74. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|